Cancer News: Generic
New research shows that the 10 most commonly asked complementary medicines interact with conventional cancer treatments, and this may be dangerous for patients.
A new study shows that nearly 500,000 new cancer cases per year can be attributed to "high body mass index" (BMI, a metric of weight compared to height).
Researchers in partnership with the industry are analyzing the science required to stop hair loss from chemotherapy and improve cancer patients' quality of life.
The US FDA has approved a drug (netupitant and palonosetron) for patients who experience nausea and vomiting while in chemotherapy.
An agent called rolapitant reduces nausea and vomiting in patients receiving cisplatin-based chemotherapy, according to the results of a phase 3 trial.
Children exposed to chemotherapy/radiotherapy while in the womb suffer no negative mental or heart-related development impacts, based on international studies.
New research conducted in labs suggests that exercise may boost the effectiveness of chemotherapy in shrinking tumors.
E-cigarettes may not be helping cancer patients to quit smoking, based on a new study.
A new approach to treating cancer can deliver personalized radiation therapy during surgery, reducing duration of radiation after surgery & healthy tissue risk.
Recent studies reveal that around 75% of cancer patients with major depression are not receiving treatment for it. A new program can improve quality of life.
A study of 5 million people showed that larger body size is linked with 10 common cancer types incl. uterine, gallbladder, kidney, cervical, thyroid & leukemia.
Swallowing exercises can help to minimize the risk for dysphagia in patients undergoing radiotherapy (RT) for head and neck cancer, a case study suggests.
For HIV-infected patients with cancer undergoing chemotherapy, the integrase strand-transfer inhibitor raltegravir is the best choice for viral suppression, according to a new study.
Research shows that cancer patients who were married at the time of diagnosis live markedly longer compared to unmarried ones.
ECC 2013: Survival after cancer diagnosis in Europe strongly associated with government health care expenditure
The more an EU (European Union) national government spends on health, the fewer the deaths after a cancer diagnosis in that country, according to new research presented to the 2013 European Cancer Congress (ECC2013) and published simultaneously in Annals of Oncology.
Molecular profiling identified treatable targets in 80% of 1,400 patients with cancer of unknown primary (CUP) site, leading to improved treatment and evidence of clinical benefit, according to a study reported at ECCO2013 in Amsterdam.
Cancer Research UK scientists have found a way of delivering drugs more effectively to treat life-threatening cancers that have spread to the brain, according to research published in the Journal of the National Cancer Institute.
Cancer costs countries in the European Union 126 billion euro a year, according to the first EU-wide analysis of the economic impact of the disease.
The specialised cancer agency of the World Health Organization, the International Agency for Research on Cancer (IARC), announced that it has classified outdoor air pollution as carcinogenic to humans.
Research performed at the Center of Research and Advanced Studies (Cinvestav) has identified that certain food and lifestyle habits can turn on or off the expression of cancer related genes.
Older men and women who used the internet were more likely to participate in screening for colorectal cancer, participate in physical activities, eat healthily, and smoke less, compared with those who did not use the internet, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Doctors can reassure patients that being depressed does not increase one's risk of cancer, French researchers say.
A type of HIV medicine that stops the AIDS virus from entering immune system cells could in future be put to work against cancer in new combination therapies being developed by drug companies.
The American Society of Clinical Oncology (ASCO) announced its second “Top Five” list of opportunities to improve the quality and value of cancer care. Published in the Journal of Clinical Oncology (JCO), ASCO’s second Top Five list was released as part of the Choosing Wisely® campaign, sponsored by the ABIM Foundation, to encourage conversations between physicians and patients aimed at curbing the use of certain tests and procedures that are not supported by clinical research. One of the first nine medical societies to join the Choosing Wisely campaign, ASCO issued its first Top Five list in April 2012.
A pilot initiative conducted at Mount Sinai Hospital offers compelling evidence that establishing standardized criteria for calling a palliative care consultation improves the quality of care for patients hospitalized with advanced cancer. The investigators saw improvements in the use of hospice services, inpatient mortality, and hospital readmissions among patients offered the intervention.
New research details how a sensor that can be implanted under the skin for over 1 year is able to monitor inflammation and detect nitric oxide - a molecule that has been found to show disturbed levels in the presence of some cancers. This is according to a study published in the journal Nature Nanotechnology.
The risk of venous thromboembolism (VTE) almost doubled over an 8.5-month period among cancer patients receiving chemotherapy, a retrospective cohort study showed.
Extensive statistical analyses of the mutation distribution in several thousand cancerous tumours make it possible to find cures for types of cancer that cannot be treated today.
A class of drugs used to treat parasitic infections such as malaria may also be useful in treating cancers and immune-related diseases, a new WSU-led study has found.
Two very different diseases, rheumatoid arthritis and some cancers, share a common feature - an over-abundance of a "glue" molecule that helps cells stick together. Now, a new study suggests targeting this molecule could help treat both.